BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12559014)

  • 1. Investigations into the role of anti-HLA class II antibodies in TRALI.
    Kao GS; Wood IG; Dorfman DM; Milford EL; Benjamin RJ
    Transfusion; 2003 Feb; 43(2):185-91. PubMed ID: 12559014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs.
    Kopko PM; Paglieroni TG; Popovsky MA; Muto KN; MacKenzie MR; Holland PV
    Transfusion; 2003 Feb; 43(2):177-84. PubMed ID: 12559013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II antibodies in transfusion-related acute lung injury.
    Kopko PM; Popovsky MA; MacKenzie MR; Paglieroni TG; Muto KN; Holland PV
    Transfusion; 2001 Oct; 41(10):1244-8. PubMed ID: 11606823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
    Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
    Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies.
    Sachs UJ; Wasel W; Bayat B; Bohle RM; Hattar K; Berghöfer H; Reil A; Bux J; Bein G; Santoso S; Weissmann N
    Blood; 2011 Jan; 117(2):669-77. PubMed ID: 21030555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
    Jug R; Anani W; Callum J
    Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
    Nicolle AL; Chapman CE; Carter V; Wallis JP
    Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome.
    Win N; Massey E; Lucas G; Sage D; Brown C; Green A; Contreras M; Navarrete C
    Hematology; 2007 Oct; 12(5):461-9. PubMed ID: 17852461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury.
    Nishimura M; Hashimoto S; Takanashi M; Okazaki H; Satake M; Nakajima K
    Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we underestimating reverse TRALI?
    De Clippel D; Emonds MP; Compernolle V
    Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
    Nakagawa M; Toy P
    Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of transfusion-related acute lung injury triggered by HLA and anti-HLA antibody reaction.
    Lee JH; Kang ES; Kim DW
    J Korean Med Sci; 2010 Sep; 25(9):1398-403. PubMed ID: 20808691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of leucocyte alloantibodies in blood donors from South China.
    Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
    Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR.
    Nishimura M; Hashimoto S; Satake M; Okazaki H; Tadokoro K
    Vox Sang; 2007 Jul; 93(1):78-82. PubMed ID: 17547569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.